Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MRNA | Common Stock | Options Exercise | $41.9K | +2K | +17.29% | $20.93* | 13.6K | Oct 28, 2022 | Direct | F1 |
transaction | MRNA | Common Stock | Options Exercise | $41.9K | +2K | +14.74% | $20.93* | 15.6K | Oct 28, 2022 | Direct | F1 |
transaction | MRNA | Common Stock | Sale | -$600K | -4K | -25.7% | $150.00 | 11.6K | Oct 28, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MRNA | Stock Option (Right to Buy) | Options Exercise | $0 | -2K | -0.89% | $0.00 | 223K | Oct 28, 2022 | Common Stock | 2K | $20.93 | Direct | F1, F2 |
transaction | MRNA | Stock Option (Right to Buy) | Options Exercise | $0 | -2K | -0.9% | $0.00 | 221K | Oct 28, 2022 | Common Stock | 2K | $20.93 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2021. |
F2 | 25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |